Google Ads is too good at finding patients for most practices to walk away from. It also requires more configuration discipline than any other channel to operate without leaking data. The two facts coexist, and the practices that ignore the second one are quietly creating risk.
Google Ads is, for most medical practices, the highest-intent paid acquisition channel available. The patient who searches for a specific service in a specific location is closer to booking than the patient who saw an Instagram ad while scrolling. That intent advantage is the reason Google Ads typically delivers the lowest cost per acquired patient in a well-built marketing mix.
It is also the channel where most healthcare practices accumulate compliance exposure without realizing it. The conversion tracking, audience features, and reporting workflows that make Google Ads effective are the same features that, in the wrong configuration, transmit PHI to a platform that does not sign BAAs for its consumer ad products.
Running Google Ads for a medical practice in 2026 is not a question of whether to use the channel. It is a question of how to use it without creating the exposure the channel is structurally prone to producing.
Where the Exposure Actually Comes From
Google Ads itself, as a tool for placing search ads, does not create HIPAA exposure. The exposure comes from how the ad platform integrates with the rest of the practice’s marketing infrastructure. There are four common points of leakage.
The first is the conversion tag installed on the practice’s website. When the standard Google Ads conversion tag fires on a lead form thank-you page, it transmits data to Google including the visitor’s IP address, browser fingerprint, URL of the page where the conversion happened, and any URL parameters present on that page. If the URL or its parameters carry condition-specific or service-specific information, that information becomes part of the transmission.
The second is customer match audiences. The Google Ads feature that lets advertisers upload lists of customer emails or phone numbers for targeting purposes is convenient, and entirely inappropriate for healthcare practices to use with patient identifiers. An uploaded list of patient emails — even hashed — is, in healthcare context, a list of people associated with the practice. Targeting them through the ad platform requires data flow that consumer ad products are not configured to handle compliantly.
The third is enhanced conversions. Google’s enhanced conversions feature transmits hashed identifiers — emails, phone numbers — from converting visitors to improve attribution. In a non-healthcare context this is helpful. In healthcare, transmitting identifiers to Google for enhanced conversions can constitute a disclosure of PHI depending on what the conversion event implies about the individual.
The fourth is integrated analytics. When Google Ads is connected to Google Analytics — which is the default state of most setups — data flows between them and into Google’s broader advertising graph.
Configurations that look fine in either tool individually can create exposure when combined.
What a HIPAA-Conscious Google Ads Setup Looks Like
A defensible Google Ads configuration for a medical practice has several deliberate departures from the default.
Conversion tracking is server-side, with a tag management endpoint between the website and Google that strips problematic parameters before any data reaches the platform. The conversion event Google sees is a clean conversion — a lead happened, here is the value, here is approximately when — without the surrounding context that would make the event PHI.
URL structures are designed to avoid encoding condition or service information in the path or parameters. A thank-you page lives at a neutral URL — a generic confirmation page — rather than a path that reveals what the patient submitted. This is a site architecture decision, not a Google Ads decision, but it has direct implications for what Google can see.
Enhanced conversions are typically disabled, or configured in restricted ways that do not transmit raw identifiers. The marginal improvement in attribution accuracy is not worth the marginal increase in exposure for most healthcare practices.
Customer match audiences built from patient lists are not used. Audience targeting relies on Google’s contextual and behavioral signals applied at the ad platform’s level, not on uploaded lists that originate from the practice’s patient data.
Remarketing audiences, if used, are based on visits to non-sensitive pages only. The default “all visitors” remarketing audience is replaced with a more carefully scoped audience that excludes visitors to condition-specific pages where the visit itself reveals health information.
Account Structure as a Compliance Tool
The structure of the Google Ads account itself can reduce exposure or increase it. A few principles help.
Campaigns should be organized by service line, not by ad copy. This makes it easier to maintain different tracking configurations for different sensitivities. A behavioral health campaign and an aesthetic dermatology campaign have different compliance considerations, and treating them as separate campaigns from the start makes those differences manageable.
Negative keywords should be used aggressively to exclude searches that would route patients to high-sensitivity landing pages from ads that should be reaching less sensitive audiences. The mismatch between ad intent and landing-page sensitivity is a quiet source of unnecessary exposure.
Geographic targeting should be sufficiently narrow to keep audience sizes small enough that aggregate data does not become individually identifying. This is more relevant for smaller practices in specific markets than for larger multi-location operations.
Ad Copy Considerations
Compliance is not only an infrastructure issue. The ad copy itself has implications, although these are governed more by FTC and state advertising rules than by HIPAA.
Ad copy should avoid making absolute claims about clinical outcomes that the practice cannot substantiate. The line between effective marketing and inappropriate claims is well-trodden in healthcare advertising, and Google’s own policies enforce it more strictly than they used to. Ads disapproved for policy violations slow campaign performance and create a record of attempted claims that is worth avoiding.
Ad copy should not include language that could be construed as personalized to characteristics protected under the Americans with Disabilities Act, the Fair Housing Act, or relevant healthcare advertising rules. Google’s own restricted category rules apply to healthcare advertising and have tightened over recent years.
Patient testimonials in ad copy should be approached with caution. Testimonials are not categorically prohibited, but they bring additional considerations around authorization, accuracy claims, and the FTC’s disclosure requirements that make them more work than they often appear to be worth.
Landing Page Considerations
The landing page where Google Ads traffic arrives is the single most consequential surface in the entire campaign. It is also where most compliance considerations land.
Landing pages for paid search traffic should be specifically designed for the campaign, not the practice’s main service line pages. This matters for performance reasons — dedicated landing pages convert better — and for compliance reasons, because dedicated pages can be configured more precisely with respect to tracking, forms, and URL structure.
Forms on landing pages should collect only the information actually needed to qualify the lead. Health-context fields, free-text symptom descriptions, and detailed condition questions belong in clinical intake, not in a marketing lead form. The principle of data minimization applies as much to forms as to tracking.
Pages should disclose, in plain language, what happens to the information the visitor submits. This is good practice from an FTC perspective and reinforces appropriate expectations for the visitor. Generic privacy policies are not a substitute for clear, contextual disclosure on the page itself.
Reporting and Optimization
Once the setup is compliance-conscious, the question becomes how to optimize the campaign with less granular signal than the platform would otherwise have.
The answer is first-party measurement. The practice’s own CRM, properly connected to the Google Ads account through compliant integrations, can transmit conversion value information back to the platform without transmitting PHI. The platform learns that a certain campaign produced higher-value conversions over a given period without learning which patients converted or what they were treated for.
Optimization decisions then happen against business outcomes — cost per acquired patient by campaign, conversion rate by ad group, downstream patient value by source — rather than against platform-side micro-events. This is, in many ways, a healthier basis for optimization regardless of compliance considerations.
The Practical Path Forward
Practices currently running Google Ads with default conversion tracking and integrated analytics are in a category that most healthcare marketing setups occupy. They are not necessarily in immediate crisis, but they are running a configuration that is increasingly difficult to defend.
The practical path forward is incremental. Audit the current configuration. Identify the highest-exposure surfaces. Address them in order — typically conversion tracking first, then audience configuration, then landing page architecture. The work usually takes between a few weeks and a few months depending on the size of the account and the complexity of the site, and it does not require shutting down campaigns during the migration.
What it does require is the decision to do it. Practices that decide proactively spend less, accomplish more, and accumulate less risk than practices that wait until the question is asked by counsel or by a plaintiff’s firm.
